The Week That Was, The Week Ahead: Macro and Markets, October 25
at www.tipranks.com (Sun, 25-Oct 4:25 AM)
Eli Lilly releases promising early-stage data on ADC for ovarian cancer
at seekingalpha.com (Sat, 24-Oct 10:10 AM)
Catalyst watch: Fed meeting, earnings blitz, Oracle AI event, and a pure-play hockey stock
at seekingalpha.com (Fri, 23-Oct 3:00 PM)
at www.tipranks.com (Wed, 21-Oct 9:50 AM)
RBC Capital Remains a Buy on Eli Lilly & Co (LLY)
at www.tipranks.com (Tue, 20-Oct 9:47 PM)
Novo's CagriSema leads to 25% weight loss in women
at seekingalpha.com (Tue, 20-Oct 5:57 PM)
Novo Nordisk Stock (NVO) Climbs 2% Today on Positive CagriSema Weight-Loss Data
at www.tipranks.com (Tue, 20-Oct 3:06 PM)
Eli Lilly Stock (LLY) Hits All-Time High Ahead of Earnings
at www.tipranks.com (Tue, 20-Oct 2:33 PM)
XLV touches a new high, hitting overbought territory
at seekingalpha.com (Tue, 20-Oct 1:11 PM)
Midday Need to Know: Salesforce to acquire Braze, SpaceX earnings preview, and more
at seekingalpha.com (Tue, 20-Oct 12:27 PM)
Eli Lilly hits all-time high share price
at seekingalpha.com (Tue, 20-Oct 11:04 AM)
Lilly, METiS ink AI-driven drug delivery deal worth up to $1.1B
at seekingalpha.com (Tue, 20-Oct 9:07 AM)
Market Chameleon (Thu, 15-Oct 7:14 AM)
LLY’s AI Push Redefines Drug Discovery: Why Function-Focused Partnerships Could Change the Game
Market Chameleon (Wed, 19-Aug 9:18 AM)
Lilly Raises 2026 Outlook as Mounjaro and Zepbound Drive 48% Revenue Surge, Pipeline Momentum Builds
Market Chameleon (Wed, 5-Aug 7:12 AM)
Market Chameleon (Mon, 3-Aug 8:17 AM)
